Merit Medical Systems, Inc.
MMSI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.78 | 1.84 | 1.03 | -0.12 |
| FCF Yield | 3.25% | 2.48% | 1.73% | 3.41% |
| EV / EBITDA | 20.33 | 20.22 | 23.31 | 24.41 |
| Quality | ||||
| ROIC | 5.65% | 4.89% | 5.35% | 3.80% |
| Gross Margin | 47.43% | 46.44% | 45.10% | 45.16% |
| Cash Conversion Ratio | 1.83 | 1.54 | 1.53 | 3.04 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.63% | 5.37% | 6.09% | 2.61% |
| Free Cash Flow Growth | 68.52% | 56.58% | -41.94% | 2.84% |
| Safety | ||||
| Net Debt / EBITDA | 1.40 | 1.31 | 1.16 | 1.61 |
| Interest Coverage | 4.99 | 7.99 | 13.81 | 11.58 |
| Efficiency | ||||
| Inventory Turnover | 2.33 | 2.22 | 2.38 | 2.66 |
| Cash Conversion Cycle | 177.86 | 183.88 | 170.67 | 161.68 |